Clinical review demonstrates stepwise and personalised pharmacological strategies in children with asthma, suggesting enhanced adherence and improved symptom control.
Asthma is a chronic respiratory disease that causes recurrent symptoms such as wheeze, shortness of breath and cough. It is characterised by airway inflammation and hyperresponsiveness and variable expiratory airflow. Pharmacological management of paediatric asthma involves a stepwise approach, with inhaled corticosteroids as the mainstay of therapy. Maintenance-and-reliever therapy using a single inhaler containing a combination of an inhaled corticosteroid plus formoterol is recommended as both maintenance treatment and for the relief of acute asthma symptoms, which can improve treatment adherence. A personalised approach to paediatric asthma treatment can involve the use of biologics (reserved for the treatment of severe, uncontrolled asthma) and genotype-directed prescribing.
No takes yet. Share an insight, caveat, or question.
Kimberley Chen (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: